pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 6·1 min read
save

Salk Institute President Warns of NIH Funding Cuts While Embracing AI and Brain Research Initiatives

Jul 6, 2026·read at Endpoints ↗RegulatoryNeutral

Gerald Joyce, president of the Salk Institute, highlighted recent reductions in NIH funding and their impact on research institutions.

He said the institute is fully committing resources to artificial intelligence to accelerate discovery, especially in neuroscience.

Joyce also noted that 2026 has been designated the Year of the Brain, providing a thematic focus for collaborative projects.

He emphasized the need for diversified funding sources to sustain the institute’s mission amid budget pressures.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Salk Institute’s president on NIH cuts, ‘all in’ on AI, and the Year of the Brain”

read at Endpoints ↗
98 words · retrieved Jul 6
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 47m agoVerastem makes its stand as a RevMed competitor in pancreatic cancerEndpoints
  • 2h agoUltragenyx's second PRV sale; Biomea's oral GLP-1 data leads to stock slumpEndpoints
  • 4h agoVir makes solid tumor T cell engager deal with GileadEndpoints
  • 5h agoArrowhead’s brain-targeting RNA drug lowers Alzheimer’s protein in early studyEndpoints
  • 5h agoZealand inks up to $1.3B deal for AI-designed obesity treatmentsEndpoints